Man Group PLC Legend Biotech Corp Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $212,546 - $303,809	-5,478 Reduced 23.89%	17,449 $871,000
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $515,025 - $770,850	13,500 Added 143.21%	22,927 $935,000
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $6,708 - $11,000	-200 Reduced 2.08%	9,427 $518,000
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $298,629 - $463,828	9,627 New	9,627 $350,000

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.